首页> 外国专利> cancer treatment methods, egfr antagonist-resistant cancer cells, cancer cells, methods of increasing the sensitivity and effectiveness of cancer treatment, and methods of delaying, treating cancer patients and extending

cancer treatment methods, egfr antagonist-resistant cancer cells, cancer cells, methods of increasing the sensitivity and effectiveness of cancer treatment, and methods of delaying, treating cancer patients and extending

机译:癌症治疗方法,例如抗frant拮抗剂癌细胞,癌细胞,提高癌症治疗敏感性和有效性的方法以及延迟,治疗癌症患者和延长治疗的方法

摘要

Summary “egfr antagonist-resistant cancer, cancer cell and cancer treatment methods, methods of increasing the sensitivity and effectiveness of cancer treatment, and methods of delaying, treating individuals with cancer and extending” are provided in the present combination therapies for the treatment of pathological conditions such as cancer using fgfr signaling antagonists.
机译:总结在本发明的组合疗法中提供了“抗egfr拮抗剂的癌症,癌细胞和癌症的治疗方法,提高癌症治疗的敏感性和有效性的方法以及延迟,治疗患有癌症的个体并扩展其的方法”使用fgfr信号拮抗剂的癌症等疾病。

著录项

  • 公开/公告号BR112015021423A2

    专利类型

  • 公开/公告日2017-07-18

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号BR20151121423

  • 发明设计人 AVI ASHKENAZI;ROBERT L. YAUCH;XIAOFEN YE;

    申请日2014-03-06

  • 分类号A61K45/06;A61K31/4706;A61K31/517;A61P35;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号